INTUITIVE SURGICAL, INC.

(ISRG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Intuitive Receives FDA Clearance for 8 mm SureForm 30 Curved-Tip Stapler

12/15/2021 | 08:45am EDT

Intuitive announced that the U.S. Food & Drug Administration (FDA) cleared the company’s fully wristed, 8 mm SureForm 30 Curved-Tip Stapler and reloads (gray, white, and blue) for use in general, thoracic, gynecologic, urologic, and pediatric surgery. The 8 mm SureForm 30 stapler is expected to launch in the U.S. in 2022, with other countries to follow. It has been designed to help surgeons better visualize and reach anatomy through a combination of the 8 mm diameter instrument shaft and jaws, 120-degree cone of wristed articulation, and the curved tip. As it fits through the 8 mm da Vinci surgical system instrument cannula, the stapler allows different angles for surgeons to approach patient anatomy. As with the other SureForm staplers, the 8 mm SureForm 30 Curved-Tip Stapler integrates SmartFire technology - software that optimizes staple line performance by measuring tissue compression before and during staple firing. The SmartFire technology makes automatic adjustments to the firing process as staples are formed and the transection is made. The technology makes more than 1,000 measurements per second, helping achieve a consistent staple line.


© S&P Capital IQ 2021
All news about INTUITIVE SURGICAL, INC.
05/17Citigroup Adjusts Intuitive Surgical's Price Target to $305 From $360, Reiterates Buy R..
MT
05/10TRANSCRIPT : Intuitive Surgical, Inc. Presents at Bank of America 2022 Healthcare Conferen..
CI
05/04IPR JEOPARDY : Estoppel Pitfalls For Multiple Concurrently Filed Petitions
AQ
05/03INTUITIVE SURGICAL INC : Change in Directors or Principal Officers, Submission of Matters ..
AQ
04/28INSIDER SELL : Intuitive Surgical
MT
04/22INTUITIVE SURGICAL INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
04/22Tranche Update on Intuitive Surgical, Inc.'s Equity Buyback Plan announced on February ..
CI
04/22Wall St tumbles as investors fret on weak earnings, rate hikes
RE
04/22Wall St benchmarks drop 2% on weak earnings, rate hike worries
RE
04/22Wall St benchmarks drop 2% on weak earnings, rate hike worries
RE
More news
Analyst Recommendations on INTUITIVE SURGICAL, INC.
More recommendations
Financials (USD)
Sales 2022 6 377 M - -
Net income 2022 1 513 M - -
Net cash 2022 2 160 M - -
P/E ratio 2022 52,7x
Yield 2022 -
Capitalization 78 303 M 78 303 M -
EV / Sales 2022 11,9x
EV / Sales 2023 10,3x
Nbr of Employees 9 793
Free-Float 99,5%
Chart INTUITIVE SURGICAL, INC.
Duration : Period :
Intuitive Surgical, Inc. Technical Analysis Chart | ISRG | US46120E6023 | MarketScreener
Technical analysis trends INTUITIVE SURGICAL, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 218,14 $
Average target price 316,63 $
Spread / Average Target 45,2%
EPS Revisions
Managers and Directors
Gary S. Guthart Chief Executive Officer & Director
Jamie E. Samath Chief Financial Officer & Senior Vice President
Craig H. Barratt Chairman
Myriam J. Curet Chief Medical Officer & Executive Vice President
Kara Andersen Reiter Assistant General Counsel
Sector and Competitors
1st jan.Capi. (M$)
INTUITIVE SURGICAL, INC.-39.29%78 303
THERMO FISHER SCIENTIFIC-18.74%215 594
DANAHER CORPORATION-24.22%178 480
SIEMENS HEALTHINEERS AG-17.17%64 740
EDWARDS LIFESCIENCES CORPORATION-27.16%58 675
BOSTON SCIENTIFIC CORPORATION-7.04%56 454